According to a meta-analysis study, insomnia is a frequent comorbidity in schizophrenia and is associated with increased ... DocWire News recently spoke with Dr. Robert Risinger, MD, the Chief Medical Officer, Neuroscience at BioXcel ... In a recent study, researchers surveyed patient acceptability of medication formulations used to treat acute agitations ... Recently, sublingual dexmedetomidine was approved by the FDA for the treatment of agitation associated with ... According to a report published in Schizophrenia Research, overactive, aggressive, disruptive, or agitated behavior ... Dementia, a syndrome characterized by progressive cognitive and functional declines, is one of the leading causes of ... Patients with schizophrenia can and should participate in cancer screening to the same extent as the general population, ... Patients with end-stage renal disease (ESRD) may experience depression, anxiety, organic psychiatric disorders, ... Childhood exposure to the air pollutant nitrogen dioxide (NO2) is associated with an increased risk of developing ... People exposed to a pet dog at birth and during the first three years of their lives have a lower risk of developing ... Here are the top stories covered by DocWire News this week in the Hematology & Oncology section. This week, studies ... Women with schizophrenia and other psychotic disorders were about half as likely as the general population to undergo a ... For individuals at clinical high risk (CHR) for developing psychosis, poor functional outcomes are associated with ... Researchers from the University at Buffalo recently managed to control a gene that is essential in the human growth ...